CVS Health raises 2026 cash flow outlook to at least $11.5 billion

CVS Health said on its second-quarter call that it is raising its 2026 adjusted EPS guidance by $0.60 to a range of $7.90 to $8.10. CVS Health said it now expects cash flow from operations of at least $11.5 billion, an increase of $2 billion from its prior guidance.

Chief Financial Officer Brian Newman said the company's current outlook does not assume any share repurchases this year.

Quotes from the call

“We are also updating our full year expectation for cash flow from operations to at least $11.5 billion, a meaningful increase of $2 billion from our prior guidance.”

“We are also increasing our outlook for full year cash flow from operations to at least $11.5 billion, reflecting our updated earnings outlook as well as the impact of improvements in working capital.”